Side-by-Side Comparison · 2026

CagriSema vs Mazdutide

CagriSema vs Mazdutide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

CagriSema
Metabolic & Mitochondrial

9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin slows gastric emptying and promotes satiety signaling....

Calculate CagriSema dose →
Mazdutide
Metabolic & Mitochondrial

Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-sensitizing effects of GLP-1 agonism with the fat-oxidizing and energy-expenditu...

Calculate Mazdutide dose →
Key Parameters
Parameter CagriSema Mazdutide
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Phase III Phase III (China)
Half-Life - ~7 days
Typical Dose Cagrilintide 2.4 mg + Semaglutide 2.4 mg 3–9 mg
Frequency Once weekly Once weekly
Route Subcutaneous (weekly) Subcutaneous (weekly)
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate CagriSema Calculate Mazdutide
Frequently Asked Questions
What is the difference between CagriSema and Mazdutide?
CagriSema: 9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin ... Mazdutide: Mazdutide (IBI362) is a once-weekly GLP-1/glucagon receptor dual agonist developed by Innovent Biologics. By activating both receptors simultaneously, it combines the appetite suppression and insulin-...
Which has a longer half-life, CagriSema or Mazdutide?
CagriSema half-life: unknown. Mazdutide half-life: ~7 days.
Can you stack CagriSema and Mazdutide?
CagriSema and Mazdutide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.